MarketPulse

biomarker discovery

4 articles
BenzingaBenzinga··Vandana Singh

Roche Bets $1.05B on PathAI to Fortify Digital Pathology Arsenal

Roche to acquire digital pathology company PathAI for up to $1.05 billion, paying $750 million upfront with $300 million in milestone payments to strengthen AI diagnostics capabilities.
RHHBYacquisitioncompanion diagnostics
GlobeNewswire Inc.GlobeNewswire Inc.··Roche

Roche Acquires PathAI for $750M to Bolster AI-Driven Diagnostic Capabilities

Roche to acquire digital pathology company PathAI for $750M upfront plus $300M in milestones, strengthening AI-driven diagnostic capabilities and precision medicine strategy.
RHHBYAI technologyprecision medicine
GlobeNewswire Inc.GlobeNewswire Inc.··Healthcare Foresights

Genomic Revolution: Targeted DNA-RNA Sequencing Market to Hit $46.9B by 2035

Global targeted DNA-RNA sequencing market to surge from $8.6B in 2025 to $46.9B by 2035, driven by precision medicine adoption and government genomic initiatives.
ILMNRHHBYTMOBIOBIO.B+1precision medicinebiomarker discovery
GlobeNewswire Inc.GlobeNewswire Inc.··Seer, Inc.

Seer Showcases Proteograph Platform at US HUPO 2026 Conference

Seer presents its Proteograph platform at US HUPO 2026, showcasing proteomics research across cardiovascular, neurodegenerative, aging, and oncology applications using minimal sample volumes.
SEERproteomicsProteograph Product Suite